FDA red-flags liver risks for AbbVie, Merck, Gilead hep C drugs

29th August 2019 Uncategorised 0

Next-gen hepatitis C meds typically cure the disease with few side effects, but the FDA says it’s tracking rare cases of liver damage in patients using some top-selling drugs—mostly patients who shouldn’t have been using them in the first place.

More: FDA red-flags liver risks for AbbVie, Merck, Gilead hep C drugs
Source: fierce